| Unique ID issued by UMIN | UMIN000059903 |
|---|---|
| Receipt number | R000068509 |
| Scientific Title | Safety and efficacy of home-based neuromuscular electrical stimulation device in patients with Charcot-Marie-Tooth disease: a randomized controlled crossover trial |
| Date of disclosure of the study information | 2025/12/01 |
| Last modified on | 2025/11/27 16:33:42 |
Safety and efficacy of home-based neuromuscular electrical stimulation device in patients with Charcot-Marie-Tooth disease: a randomized controlled crossover trial
Neuromuscular electrical stimulation (NMES) training in CMT
Safety and efficacy of home-based neuromuscular electrical stimulation device in patients with Charcot-Marie-Tooth disease: a randomized controlled crossover trial
Neuromuscular electrical stimulation (NMES) training in CMT
| Japan |
Charcot-Marie-Tooth disease
| Neurology |
Others
NO
To evaluate the efficacy and safety of the NMES device "FootFit" (MTG Co.,Ltd.) in improving muscle strength and functional outcomes in patients with CMT.
Safety,Efficacy
Lower leg muscle strength
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
No treatment
2
Educational,Counseling,Training
| Device,equipment |
Neuromuscular electrical stimulation training for lower leg muscles
Control
| 20 | years-old | <= |
| Not applicable |
Male and Female
Eligible participants were aged 20 years or older with a confirmed diagnosis of CMT by genetic testing. Additionally, participants were required to be ambulatory with or without support.
Exclusion criteria were as follows: no muscle contraction of the lower leg muscles observed with the NMES device; History of lower extremity trauma; already undergoing NMES training at the time of informed consent; comorbid peripheral neuropathy other than CMT or muscle disease; use of medications that may affect nerves or muscles; or excessive alcohol consumption; presence of implantable medical electrical devices such as pacemakers; presence of metallic implants such as metal plates in the lower extremities; pregnant or lactating women; any other safety-related reasons deemed inappropriate for study participation by the principal investigator or co-investigators.
40
| 1st name | Yu-ichi |
| Middle name | |
| Last name | Noto |
Kyoto prefectural university of medicine hospital
Department of Neurology
602-8566
465 Kajii-cho, Kamigyo-ku, Kyoto 602-0841, Japan
075-251-5794
y-noto@koto.kpu-m.ac.jp
| 1st name | Yu-ichi |
| Middle name | |
| Last name | Noto |
Kyoto prefectural university of medicine hospital
Department of Neurology
602-8566
465 Kajii-cho, Kamigyo-ku, Kyoto 602-0841, Japan
075-251-5794
y-noto@koto.kpu-m.ac.jp
Kyoto prefectural university of medicine
Yuichi Noto
MHLW Research on rare and intractable diseases Program Grant Number JPMH23FC1008
Japanese Governmental office
Kyoto Prefectural University of Medicine, Clinical Research Review Board
465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JAPAN.
075-251-5337
rinri@koto.kpu-m.ac.jp
YES
jRCTs052210206
jRCT
| 2025 | Year | 12 | Month | 01 | Day |
Unpublished
20
Regarding safety, no adverse event associated with the use of the NMES device occurred throughout the present study.
Completed
| 2021 | Year | 09 | Month | 28 | Day |
| 2022 | Year | 03 | Month | 25 | Day |
| 2022 | Year | 11 | Month | 17 | Day |
| 2025 | Year | 05 | Month | 13 | Day |
| 2025 | Year | 10 | Month | 28 | Day |
| 2025 | Year | 10 | Month | 28 | Day |
| 2025 | Year | 12 | Month | 01 | Day |
| 2025 | Year | 11 | Month | 27 | Day |
| 2025 | Year | 11 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068509